Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Diadema Partners Lp
Form 13F · Q2 2026

Diadema Partners Lp

CIK 2026172申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$7.9亿
申报组合市值
149
持仓数量
7
Quarters on record
Top 50
持仓数量

Diadema Partners Lp——持仓

共 149 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1UTHR United Therapeutics Corp Del52,989+94.1%$2871万3.6%
2RVMD Revolution Medicines Inc139,218+72.1%$2607万3.3%
3ABVX Abivax Sa163,644+115.5%$2160万2.7%
4COGT Cogent Biosciences Inc493,664+52.9%$1910万2.4%
5BMRN Biomarin Pharmaceutical Inc312,846+111.1%$1790万2.3%
6VKTX Viking Therapeutics Inc441,808−15.9%$1723万2.2%
7EWTX Edgewise Therapeutics Inc272,214—$1106万1.4%
8KOD Kodiak Sciences Inc218,117+13.0%$850万1.1%
9IMCR Immunocore Hldgs Plc254,863+31.9%$809万1.0%
10FDMT 4D Molecular Therapeutics In571,107—$760万1.0%
11RCUS Arcus Biosciences Inc223,810−6.0%$690万0.9%
12JNJ Johnson & Johnson22,000−59.1%$559万0.7%
13NVO Novo-Nordisk A S100,000+586.0%$481万0.6%
14CRVS Corvus Pharmaceuticals Inc294,811+20.4%$440万0.6%
15RLAY Relay Therapeutics Inc230,677—$432万0.5%
16ZYME Zymeworks Inc142,132+0.0%$372万0.5%
17BIOA Bioage Labs Inc146,334+143.9%$359万0.5%
18TSHA Taysha Gene Therapies Inc522,619—$356万0.4%
19NRIX Nurix Therapeutics Inc121,539—$295万0.4%
20CRBP Corbus Pharmaceuticals Hldgs301,264−31.5%$283万0.4%
21INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc67,512−5.4%$277万0.4%
22IVA Inventiva Sa740,786+110.2%$273万0.3%
23ORKA Oruka Therapeutics Inc27,799—$265万0.3%
24PCVX Vaxcyte Inc45,071+79.8%$262万0.3%
25RLMD Relmada Therapeutics Inc361,367+79.9%$250万0.3%
26VERA Vera Therapeutics Inc57,608—$247万0.3%
27CTNM Contineum Therapeutics Inc119,733—$196万0.2%
28BCYC Bicycle Therapeutics Plc462,724−2.9%$196万0.2%
29GLUE Monte Rosa Therapeutics Inc78,391−58.1%$190万0.2%
30VRDN Viridian Therapeutics Inc100,000—$184万0.2%
31MGNX Macrogenics Inc374,403−37.6%$173万0.2%
32PRQR Proqr Thrapeutics N V926,016+414.2%$172万0.2%
33SPRB Spruce Biosciences Inc30,000+200.0%$162万0.2%
34ARDX Ardelyx Inc303,025—$155万0.2%
35CUE Cue Biopharma Inc48,369—$153万0.2%
36MLYS Mineralys Therapeutics Inc56,347+113.9%$152万0.2%
37PRTA Prothena Corp Plc149,482—$146万0.2%
38VYGR Voyager Therapeutics Inc413,642−2.4%$145万0.2%
39UNCY Unicycive Therapeutics Inc303,676+186.3%$142万0.2%
40PHAT Phathom Pharmaceuticals Inc129,950+137.8%$141万0.2%
41SYRE Spyre Therapeutics Inc15,000—$133万0.2%
42HELP Cybin Inc200,000—$132万0.2%
43EQ Equillium Inc400,282−7.7%$128万0.2%
44XERS Xeris Biopharma Holdings Inc132,746+0.0%$105万0.1%
45PHVS Pharvaris N V29,321+0.0%$101万0.1%
46HRMY Harmony Biosciences Hldgs In26,864−71.1%$98万0.1%
47RNAC Cartesian Therapeutics Inc87,057—$91万0.1%
48RIGL Rigel Pharmaceuticals Inc22,816—$89万0.1%
49SMMT Summit Therapeutics Inc60,000—$87万0.1%
50PGEN Precigen Inc135,293+144.7%$77万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。